The “Washington Ways Without Means” session was moderated by Nick Ferreyros, managing director of policy, advocacy, and ...

Drug acquisition costs are trackable, but operational inputs—training time, monitoring intensity, site activation, and ...

Experts tackled CAR T access, trial equity, and overtreatment in breast cancer at an AJMC Institute for Value-Based Medicine ...

Grace Mackleby, PhD, explores why dually eligible beneficiaries more often switch MA plans than leave for traditional ...

Mayo Clinic's Scott Soefje, PharmD, MBA, explains how logistics, contracts, and cost shape access to new cancer drugs and ...

Symptom tracking can recalibrate perceptions of “normal” menstruation, increase self-management behaviors, and prompt ...

The analysis found a nonlinear association between systemic inflammation and overactive bladder, with stronger links at higher inflammation levels. Higher levels of systemic inflammation were ...

Adoption data show a want–execution gap: AI use/experimentation exceeds 80%, but only 19% report deployed solutions, with cost, cybersecurity, and workflow disruption as leading barriers. The 2026 COA ...

Novel combinations may improve survival in Richter transformation, a hard-to-treat condition, says Adam Kittai, MD, of Perlmutter Cancer Center.

Caregiver shortages limit access to transplant, CAR T, and bispecific therapies, and no system offers replacement support, ...

MYR301 enrolled 150 patients (≈47% cirrhosis) and compared bulevirtide 2 mg vs 10 mg vs delayed-start, followed by 96 weeks off-therapy observation. End-of-treatment undetectable HDV RNA favored ...

Combined immunonutrient formulas were associated with fewer postoperative complications, with the most reproducible signal in reduced surgical site/wound infection rates. Single-component ...